Latest tumor Stories
[ Watch the Video: Fighting Prostate Cancer with Red Wine ] Lee Rannals for redOrbit.com - Your Universe Online A compound in grape skins and red wine may be able to help fight off prostate cancer, according to a new study published in the Journal of Andrology and Cancer Science. Resveratrol, which is found in grape skins and red wine, has been shown to have several beneficial effects on human health in past studies, aiding cardiovascular health and stroke prevention. The latest...
NATICK, Mass., Oct. 31, 2012 /PRNewswire/ -- Karyopharm Therapeutics Inc., leading the new field of nuclear transport modulators, announces the publication of several articles covering its SINE compounds in a variety of cancers. Because SINE CRM1 antagonists return multiple tumor suppressor proteins (TSPs) to the nucleus, activating their anti-cancer functions, they show broad activity across multiple tumor types. In addition to the publications in Acute Myeloid Leukemia announced...
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., Oct. 29, 2012 /PRNewswire/ -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the U.S. Food and Drug Administration (FDA) granted priority review to the New Drug Application (NDA) filed at the end of August 2012 for Stivarga(®) (regorafenib) tablets to treat patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with two...
BOSTON, Oct. 29, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) yesterday unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) today unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
MADISON, Wis., Oct. 25, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center (UWCCC), a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404 (LIGHT), a cancer-targeted PET imaging agent, in patients with nine solid...
Cancer Treatment Centers of America at Midwestern Regional Medical Center offers new options for breast cancer patients with Autologous Fat Transfer ZION, Ill., Oct. 24, 2012 /PRNewswire-USNewswire/ -- Individualized care is the foundation of a new innovation in cancer treatment at Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern). CTCA at Midwestern is now using Autologous Fat Transfer, which is also referred to as fat grafting, to...
SAN DIEGO, Oct. 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat solid tumor cancers, announced positive preliminary results from a Phase II multicenter trial investigating the use of ImmunoPulse in Merkel cell carcinoma (MCC) patients at the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2012). The data suggest that ImmunoPulse, which...
redOrbit staff & Wire Reports – Your Universe Online Experts at the Baylor College of Medicine (BCM) have started using a new DNA sequencing technique they say will help devise individualized, more effective methods of treating breast cancer. According to oncologists at the BCM Lester and Sue Smith Breast Center, the methods used to treat a patient's cancer are dependent upon several factors, including the size of the tumor, its biological state, the stage the illness is currently...
Michael Harper for redOrbit.com – Your Universe Online It’s a debate nearly as old as cell phones themselves: Whether these mobile devices can cause brain tumors or if they pose no direct danger to humans. While study after study has been performed which proves and disproves both sides, an Italian court has taken it upon themselves to make an official ruling on the matter. According to Reuters, the Supreme Court of Italy has upheld a ruling which said one business executive’s...
